SG11202003333WA - Bordetella strains expressing serotype 3 fimbriae - Google Patents

Bordetella strains expressing serotype 3 fimbriae

Info

Publication number
SG11202003333WA
SG11202003333WA SG11202003333WA SG11202003333WA SG11202003333WA SG 11202003333W A SG11202003333W A SG 11202003333WA SG 11202003333W A SG11202003333W A SG 11202003333WA SG 11202003333W A SG11202003333W A SG 11202003333WA SG 11202003333W A SG11202003333W A SG 11202003333WA
Authority
SG
Singapore
Prior art keywords
fimbriae
strains expressing
bordetella strains
expressing serotype
serotype
Prior art date
Application number
SG11202003333WA
Inventor
Anne-Sophie Debrie
Dominique Raze
Camille Locht
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of SG11202003333WA publication Critical patent/SG11202003333WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202003333WA 2017-10-18 2018-10-18 Bordetella strains expressing serotype 3 fimbriae SG11202003333WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762574068P 2017-10-18 2017-10-18
PCT/EP2018/078522 WO2019077028A1 (en) 2017-10-18 2018-10-18 Bordetella strains expressing serotype 3 fimbriae

Publications (1)

Publication Number Publication Date
SG11202003333WA true SG11202003333WA (en) 2020-05-28

Family

ID=64664226

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003333WA SG11202003333WA (en) 2017-10-18 2018-10-18 Bordetella strains expressing serotype 3 fimbriae

Country Status (8)

Country Link
US (2) US11446372B2 (en)
EP (1) EP3697439A1 (en)
JP (2) JP7335874B2 (en)
CN (1) CN111278456B (en)
AU (1) AU2018353409A1 (en)
CA (1) CA3077428A1 (en)
SG (1) SG11202003333WA (en)
WO (1) WO2019077028A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007224734C1 (en) * 2006-03-10 2016-07-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Live attenuated Bordetella strains as a single dose vaccine against whooping cough
US20120177688A1 (en) 2009-04-28 2012-07-12 Institut Pasteur De Lille Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
JP2023550052A (en) 2020-11-17 2023-11-30 イリアド バイオテクノロジーズ，リミテッド ライアビリティ カンパニー Treatment and prevention of neuropathology associated with neurodegenerative diseases

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1236971B (en) * 1989-11-03 1993-05-07 Eniricerche Spa PROMOTING REGION OF GENES CODING THE PILIMIC SUBUNITIES FIM2, FM3 AND FIMX OF BORDETELLA PERTUSSIS AND THEIR USE FOR THE EXPRESSION OF GENES THAT CODE A PROTEIN OF INTEREST.
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (en) 1994-04-19 1996-06-14 Pasteur Institut Recombinant proteins of the filamentous hemagglutinin of Bordetella, in particular, B. Pertussis, production and application to the production of foreign proteins or vaccinating active principles.
FR2754543B1 (en) * 1996-10-11 1998-12-31 Pasteur Institut BORDETELLA STRAIN DEFICIENT IN TOXIN PRODUCTION AND EXPRESSING HYDRID PROTEIN, LIPOSOMES COMPRISING FHA AND THEIR USES AS VACCINES, AND THE USE OF FHA TO STIMULATE IMMUNE RESPONSES
FR2840319B1 (en) 2002-05-30 2004-08-20 Pasteur Institut BORDETELLA STRAINS MADE DEFICIENT BY GENETIC ATTENUATION
CA2522007A1 (en) 2003-04-11 2004-10-28 Medimmune, Inc. Methods of preventing or treating respiratory conditions
GB0402131D0 (en) * 2004-01-30 2004-03-03 Isis Innovation Delivery method
AU2007224734C1 (en) * 2006-03-10 2016-07-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Live attenuated Bordetella strains as a single dose vaccine against whooping cough
EP2069503B1 (en) 2006-11-15 2016-01-06 Folia Biotech Inc. Papaya mosaic virus-based vaccines for influenza
CA2678698A1 (en) 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
CN100537767C (en) * 2007-04-29 2009-09-09 中国药品生物制品检定所 Recombinant expressed and the application of pertussis vaccine protective antigen
CN101790534A (en) 2007-06-18 2010-07-28 半球生物制药公司 Early intervention of viral infections with immune activators
US20120177688A1 (en) 2009-04-28 2012-07-12 Institut Pasteur De Lille Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
EP2944320A1 (en) 2009-06-15 2015-11-18 National University of Singapore Influenza vaccine, composition, and methods of use
US9415077B2 (en) * 2011-11-02 2016-08-16 Institut National De La Sante Et De La Recherche Medicale Effect of an attenuated Bordetella strain against allergic disease
CA2879939A1 (en) * 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
EP2722338A1 (en) * 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
CN114767718A (en) * 2016-03-29 2022-07-22 里尔巴斯德研究所 Mutant bordetella strains and methods of use thereof
US10799573B2 (en) * 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
WO2018213361A1 (en) * 2017-05-15 2018-11-22 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
JP7404226B2 (en) * 2017-07-18 2023-12-25 セラム インスティテュート オブ インディア プライベート リミティド Immunogenic compositions with improved stability, high immunogenicity, and reduced reactogenicity, and processes for their preparation.
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
US12036405B2 (en) * 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring
WO2020049133A1 (en) 2018-09-05 2020-03-12 National University Of Singapore Adenylate cyclase catalytic domain deficient bordetella strains

Also Published As

Publication number Publication date
WO2019077028A4 (en) 2019-06-27
EP3697439A1 (en) 2020-08-26
CN111278456A (en) 2020-06-12
JP2023109996A (en) 2023-08-08
US11446372B2 (en) 2022-09-20
JP7335874B2 (en) 2023-08-30
WO2019077028A1 (en) 2019-04-25
JP2021500325A (en) 2021-01-07
CN111278456B (en) 2024-08-09
US20220362369A1 (en) 2022-11-17
AU2018353409A1 (en) 2020-04-16
US20200297833A1 (en) 2020-09-24
CA3077428A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
IL283979B (en) 1,3-thiazol-2-yl substituted benzamides
SG11202003333WA (en) Bordetella strains expressing serotype 3 fimbriae
HK1256630B (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
DK3303357T3 (en) VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 5
GB201701998D0 (en) Compact interferometer
IL249122A0 (en) Imidazol- or 1,2,4-triazol-derivatives and their use
SI3463782T1 (en) Compactor
GB201616022D0 (en) Compositions comprising bacterial strains
PL3237321T3 (en) Articulating rolling compactor attachment
GB201718698D0 (en) Compactor
GB201705733D0 (en) Novel pneumococcal vacine
GB201707014D0 (en) Transfer medium
GB201708312D0 (en) Compositions comprising bacterial strain
EP3571352C0 (en) Roller compactor
GB201616016D0 (en) Compositions comprising bacterial strains
GB201616018D0 (en) Compositions comprising bacterial strains
AU4985P (en) PP.1026 Cucurbita moschata
AU2015140V (en) Sunbel 0579 Calibrachoa sp.
AU2015134V (en) Sunbel 0778 Calibrachoa sp.
GB201604924D0 (en) Compositions comprising bacterial strains
GB201604920D0 (en) Compositions comprising bacterial strains
GB201604566D0 (en) Compositions comprising bacterial strains
GB201603786D0 (en) Compositions comprising bacterial strains
GB201603817D0 (en) Compositions comprising bacterial strains
GB201510984D0 (en) Rod coupling kits 1&2